BRIEF published on 11/06/2024 at 18:05, 14 days 19 hours ago Eiffel Tower Company: Planned capital increase of 600 million euros Capital Increase General Assembly Eiffel Tower Society SMABTP Group Banking Covenants
BRIEF published on 11/04/2024 at 18:05, 16 days 19 hours ago Eiffel Tower Company: Details on Shares and Voting Rights Share Capital Voting Rights Actions Regulation Financial Markets
BRIEF published on 10/01/2024 at 18:05, 1 month 19 days ago Société de la Tour Eiffel - Number of shares and voting rights as of September 30, 2024 Share Capital Voting Rights Actions 2024 Eiffel Tower Society
BRIEF published on 09/05/2024 at 18:05, 2 months 15 days ago STE: Number of shares and voting rights as of August 31, 2024 Financial Information Share Capital Voting Rights Eiffel Tower Society STE Actions
BRIEF published on 08/01/2024 at 18:05, 3 months 19 days ago Number of shares and voting rights as of July 31, 2024 for the Société de la Tour Eiffel Share Capital Voting Rights Actions Eiffel Tower Society July 2024
BRIEF published on 07/25/2024 at 18:05, 3 months 26 days ago Availability of the 2024 Half-Year Financial Report of the Société de la Tour Eiffel Financial Report 2024 Financial Markets Provision Eiffel Tower Society
BRIEF published on 07/23/2024 at 18:05, 3 months 28 days ago Société de la Tour Eiffel - 2024 half-year results ESG Half-year Results Debt Real Estate Investments Transformation Of Heritage
PRESS RELEASE published on 07/23/2024 at 18:00, 3 months 28 days ago Société de la Tour Eiffel - 2024 Half-year results Société de la Tour Eiffel announces 2024 half-year results, implementing a adjusted Roadmap to meet market challenges and focus on sustainable growth. Key financial data and innovative projects unveiled Financial Statements Sustainable Growth Innovative Projects Société De La Tour Eiffel 2024 Half-year Results
BRIEF published on 07/11/2024 at 18:55, 4 months 9 days ago Société de la Tour Eiffel sells an office building in the Paris region Property Sale Eiffel Tower Society Wallet Offices Parisian Region
BRIEF published on 07/11/2024 at 18:50, 4 months 9 days ago Société de la Tour Eiffel sells an office building in Montigny-le-Bretonneux Real Estate Paris Strategy Transfer Eiffel Tower Society
Published on 11/21/2024 at 13:30, 27 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 27 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 57 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 57 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 57 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 22 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 42 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
